Stocks Eli Lilly and Co

More

  • picks_pans_badge.jpg

    Ahead of the weekend, CNBC asks the experts where investors should place their bets.

  • cadeuses2.jpg

    The pharmaceutical sector faces the looming "patent cliff" -- but Credit Suisse's Catherine Arnold finds lots of opportunities in the sector for the careful investor.

  • The American College Of Cardiology kicks off its annual meeting in Chicago on Saturday. What’s the trade ahead of this major meeting of heart doctors?

  • johnson_johnson2_logo.jpg

    As proxy statements pop up on www.sec.gov, investors can get a peek at who's making what. When you go to the web site, click on "Search for company filings," then click on "Companies and other filers," enter the ticker symbol, click on "Find companies" and then open up the "14A" or proxy statement.

  • Gardasil

    Merck this morning announced that it has filed for Food and Drug Administration approval of its blockbuster cervical cancer vaccine, Gardasil, for women 27-45 years old. Right now it's approved for females 9-26.

  • Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.

  • lily_air_insulin.jpg

    First, Pfizer gave up on its inhaled insulin Exubera, then NovoNordisk threw in the towel and now it looks like Lilly is going to bow out. Alkermes, which is working on a palm-sized product called, "AIR Insulin," put out a press release today saying it expects its partner on the device, Lilly, to decide next week that it will exit the deal. ALKS shares hit a new low on the news.

  • Christopher Walls, of Institutional Direct Inc., watches a monitor on the floor of  the New York Stock Exchange, Tuesday, Feb. 27,  2007, in New York. Wall Street fell sharply, joining a global stock decline sparked by growing concerns that the U.S. and Chinese economies are cooling and that U.S. stocks are about to embark on a major correction. (AP Photo/Henny Ray Abrams)

    Stocks are tumbling. Bonds yields are falling faster than Hillary Clinton's poll numbers. And fears are growing that the commodities bubble could burst. What to do?

  • The economy's worsening. So's inflation. And the stock market is tanking. What to do? CNBC asked market experts for their best investment advice. Here are some of their picks.

  • picks_pans_badge.jpg

    There's nearly $3.5 trillion dollars waiting to be invested in the markets, according to Frederic Dickson, chief market strategist  of D.A. Davidson.  So what's keeping it out?  And what should investors do in the meantime?

  • Eli Lilly's drug Zyprexa.

    U.S. regulators have rejected a long-acting injectable form of Eli Lilly and Co's blockbuster schizophrenia drug Zyprexa, the company said Thursday, sending its shares down almost 2 percent.

  • When Schering-Plough Chairman and CEO Fred Hassan recently decided to buy another $2 million worth of SGP shares in the wake of the Vytorin study takedown, the company put out a press release.

  • Healthcare spending is expected to nearly double to $4.3 trillion by 2017. Who’s most likely to benefit and can you trade it?

  • hillary_pfizer.jpg

    According to The Center for Responsive Politics' web site Pfizer Chairman and CEO Jeff Kindler has opened his wallet again for Sen. Hillary Clinton. You can see his latest "give" here. Twice now within the past year Kindler has given the maximum amount ($2,300) an individual can contribute to a candidate.

  • graphic_fast_money.jpg

    A top industry insider gives us the dish on a story of the week. Get the details now!

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • 0800213 Pfizer.jpg

    With a 5.6% dividend yield, Pfizer is currently the highest yielding stock in the Dow Jones Industrial Average and ranks 20th in yield on the S&P 500.  As a point of comparison, 30 Yr treasuries and the Lehman Aggregate Bond Index are yielding about 4.5%.  The Lehman Corporate Bond Index is yielding 5.55%. So is it the time to buy PFE?